Medical Writer · PhD Biochemistry
A decade at the bench. Now translating complex clinical evidence into regulatory documents, publications, and patient communications that move programs forward.
Domain Expertise
About
With a PhD in Biochemistry and a decade of bench-to-bedside research, I help biopharmaceutical teams communicate science with precision and purpose — across regulatory, clinical, and commercial contexts.
Portfolio
A structured IMRAD-format abstract prepared for EBMT 2024, summarising the pivotal phase III ROCKstar trial results for belumosudil in steroid-refractory chronic GvHD. Written to meet the 350-word limit with full statistical disclosure.
A conference poster presented at ASCO 2024 summarising the RATIONALE-305 phase III data in first-line HER2-negative gastric or gastro-oesophageal junction adenocarcinoma. Designed for a 90-second walk-by read time with clear hierarchy and selective data visualisation.
A 28-slide advisory board deck prepared for a European KOL meeting on optimal CAR-T sequencing in relapsed/refractory DLBCL, incorporating updated TRANSFORM and ZUMA-7 data from ASH 2024. Structured to drive 90 minutes of expert discussion.
A patient-facing plain language summary of the VIALE-A phase III trial, written to EUPATI standards for adults with AML who are not able to have intensive chemotherapy. Approved for publication on the trial sponsor's patient portal.
What Collaborators Say
Vinny has a rare combination of genuine scientific rigour and the ability to write clearly for a non-specialist audience. She turned our messy Phase II data package into a compelling regulatory narrative in three weeks. I've worked with many medical writers — she is exceptional.
Dr. Sarah Chen
Vice President, Clinical Development, Kymera Therapeutics
Working with Vinny on our ESMO abstract felt like a genuine collaboration. She asked the right scientific questions, challenged our framing in constructive ways, and delivered a submission-ready draft that captured the significance of our data far better than we had managed ourselves.
Prof. Marcus Heilbronner
Principal Investigator, Charité – Universitätsmedizin Berlin
Our patient newsletters had always been too clinical and hard to understand. Vinny rewrote them from scratch — keeping the scientific accuracy intact while making the language genuinely accessible. Patient feedback improved immediately. She understands both the science and the audience.
Dr. Amelia Okoro
Medical Affairs Director, Novartis Oncology (UK)